The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Acute‐phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: A prospective followup study
Open accessAbstract
Objective: To determine laboratory parameters that may be useful in identifying polymyalgia rheumatica (PMR) patients who require long‐term corticosteroid therapy. Methods: A prospective followup study of 94 consecutive untreated patients with PMR were assessed for relapse/recurrence for a mean of 39 months. This cohort represented all the patients diagnosed over a 4‐year period in 2 Italian secondary referral centers. Patients were monitored for clinical signs and symptoms, erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), and serum interleukin‐6 (IL‐6). IL‐6 levels were also measured in 43 controls matched to the patients for age and sex. Results: The ESR was elevated in 91.5% of the patients prior to therapy initiation, as were CRP in 98.9% and serum IL‐6 in 92.6%. Forty‐seven (50.0%) patients had at least 1 relapse/recurrence during the followup period and 24 (25.5%) had at least 2. After 4 weeks of prednisone therapy, ESR was elevated in 13.2% patients, CRP in 41.9%, and serum IL‐6 in 37.2%. IL‐6 levels remained persistently elevated in 9.9% and CRP in 8.7% of patients during the first year of followup, whereas no patient had persistently elevated ESR. Persistently elevated CRP and IL‐6 levels were significantly associated with an increased risk of relapse/recurrence. In particular, patients with persistently elevated levels of IL‐6 during the first year of therapy had the highest relative risk. Conclusion: Despite the control of clinical symptoms, corticosteroids do not adequately control the inflammatory process in a subset of patients with PMR who have persistently elevated levels of CRP and IL‐6 and who have a higher risk of relapsing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis
DASGUPTA, B., & PANAYI, G. S. (1990) · Rheumatology · doi:10.1093/rheumatology/29.6.456 · Cited by 171
Cited by
Polymyalgia rheumatica and giant-cell arteritis
Salvarani, C., Cantini, F., & Hunder, G. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61077-6 · Cited by 767
Self-citationPolymyalgia Rheumatica and Giant Cell Arteritis
Ettlinger, R. E., Hunder, G. G., & Ward, L. E. (1978) · Annual Review of Medicine · doi:10.1146/annurev.me.29.020178.000311 · Cited by 687
Dejaco, C., Duftner, C., Buttgereit, F., Matteson, E. L., & Dasgupta, B. (2016) · Rheumatology · doi:10.1093/rheumatology/kew273 · Cited by 365
Dejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S., Abril, A., Bachta, A., Balint, P., Barraclough, K., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207492 · Cited by 334
Self-citationDejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S., Abril, A., Bachta, A., Balint, P., Barraclough, K., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39333 · Cited by 312
Self-citationGonzález-Gay, M. A., Matteson, E. L., & Castañeda, S. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31825-1 · Cited by 262
Treatment of Polymyalgia Rheumatica: A Systematic Review
Hernández-Rodríguez, J. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.352 · Cited by 118
Metadata
- Authors
- Salvarani, C., Cantini, F., Niccoli, L., Macchioni, P., Consonni, D., Bajocchi, G., Vinceti, M., Catanoso, M. G., Pulsatelli, L., Meliconi, R., & Boiardi, L.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2005-02-04
- Volume
- 53
- Issue
- 1
- Pages
- 33-38
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2020229760
- Cited by
- 160
- References
- 2
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.